Angela Koehler
Angela N. Koehler is an American biochemist who is the Karl Van Tassel (1925) Career Development Professor of Chemical Biology at the Broad Institute. Her research considers the development of chemical tools to understand transcriptional regulation, and the design of next-generation pharmaceuticals.
Angela Nicole Koehler | |
|---|---|
| Alma mater | Harvard University Reed College |
| Scientific career | |
| Institutions | California Institute of Technology Harvard University Broad Institute |
| Thesis | Small molecule microarrays: A high-throughput tool for discovering protein-small molecule interactions (2003) |
| Doctoral advisor | Stuart Schreiber |
Early life and education
Koehler was an undergraduate student in biochemistry at Reed College.[1] She worked on structural studies of proteins that recognize nucleic acids, including transfer RNA and DNA.[2] She moved to Harvard University as a doctoral researcher, where she worked alongside Stuart Schreiber on strategies to understand the interactions between proteins and molecules.[citation needed]
Research and career
Koehler joined the chemical biology program at the Broad Institute, where she was made group leader for chemical genetics.[when?][citation needed] Koehler develops time-sensitive chemical tools to understand the dynamics of transcriptional regulation. Before the work of Koehler it was understood that transcription factors were "undruggable", as their inherent structural disorder compromised the binding of small-molecule ligands.[3] Her research looks to develop small-molecule probes[4] that modify proteins, which can, in turn, tune gene expression.[2][5]
Koehler is on the faculty at the Koch Institute for Integrative Cancer Research.[6] She has founded several companies, including Ligon Discovery, a drug discovery company focused on small-molecule microarrays, Kronos Bio,[7][8] a cancer therapeutics accelerator and 76Bio,[9] a biotechnology company that looks to develop targeted protein degraders.
Awards and honors
- Genome Technology Young Investigator[10]
- Broad Institute Merkin Fellow[6]
- Novartis Lectureship in Chemistry[11]
- Ono Pharma Breakthrough Science Award[12]
- Fellow of the National Academy of Sciences[13]
- National Science Foundation CAREER Award[14]
- MIT Junior Bose Award for Excellence in Teaching[15]
Selected publications
- Lua error in Module:Cite_Q at line 13: attempt to index a nil value.
- Lua error in Module:Cite_Q at line 13: attempt to index a nil value.
References
- ^ alan. "Alumni News from Reed Magazine, March '13 | Chemistry News". Retrieved 2022-10-15.
- ^ 2.0 2.1 "Angela Koehler, PhD | MIT Department of Biological Engineering". be.mit.edu. Retrieved 2022-10-15.
- ^ Henley, Matthew J.; Koehler, Angela N. (September 2021). "Advances in targeting 'undruggable' transcription factors with small molecules". Nature Reviews. Drug Discovery. 20 (9): 669–688. doi:10.1038/s41573-021-00199-0. ISSN 1474-1784. PMID 34006959. S2CID 234780718.
- ^ "Angela Koehler". Broad Institute. 2019-01-23. Retrieved 2022-10-15.
- ^ "Angela Koehler (MIT) | Target 2035". www.target2035.net. Retrieved 2022-10-15.
- ^ 6.0 6.1 "Broad announces new Merkin Institute Fellows". Broad Institute. 2013-11-22. Retrieved 2022-10-15.
- ^ "Angela Koehler, Ph.D." Kronos Bio. Retrieved 2022-10-16.
- ^ Ryan Cross (2018-11-05). "Kronos Bio". C&EN Global Enterprise. 96 (44): 38–39. doi:10.1021/cen-09644-cover6. ISSN 2474-7408. S2CID 239821660.
- ^ "Home - 76bio". Retrieved 2022-10-15.
- ^ "Angela Koehler: The Small Molecule World". GenomeWeb. 2012-12-03. Retrieved 2022-10-15.
- ^ "HBC Research Seminar October 2020". hbc.ku.edu. Retrieved 2022-10-15.
- ^ "ONO PHARMA FOUNDATION". Grantmakers.io. Retrieved 2022-10-15.
- ^ "Angela Koehler". www.nasonline.org. Retrieved 2022-10-15.
- ^ "NSF Award Search: Award # 1845464 - CAREER: Reprogramming Transcriptional Regulation by Chemical Stabilization of Repressive Homodimers". www.nsf.gov. Retrieved 2022-10-15.
- ^ "MIT School of Engineering | » Teaching Awards". Mit Engineering. Retrieved 2022-10-15.